Clene Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CLNNW and buy or sell other stocks, ETFs, and their options commission-free!About CLNNW
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.
CEORobert Dee Etherington, MBA
CEORobert Dee Etherington, MBA
Employees—
Employees—
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2013
Founded2013
Employees—
Employees—
CLNNW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume9.36K
Average volume9.36K
High today$0.0299
High today$0.0299
Low today$0.0261
Low today$0.0261
Open price$0.0261
Open price$0.0261
Volume730.00
Volume730.00
52 Week high$0.079
52 Week high$0.079
52 Week low$0.022
52 Week low$0.022